GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Loans Receivable

OKUR (OnKure Therapeutics) Loans Receivable : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is OnKure Therapeutics Loans Receivable?

OnKure Therapeutics's Loans Receivable for the quarter that ended in Dec. 2024 was $0.00 Mil.


OnKure Therapeutics Loans Receivable Historical Data

The historical data trend for OnKure Therapeutics's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OnKure Therapeutics Loans Receivable Chart

OnKure Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Loans Receivable
- - -

OnKure Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Loans Receivable Get a 7-Day Free Trial Premium Member Only - - - - -

OnKure Therapeutics Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


OnKure Therapeutics Loans Receivable Related Terms

Thank you for viewing the detailed overview of OnKure Therapeutics's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


OnKure Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.